Thermopylae Holdings Ltd.
10% Owner

Thermopylae Holdings Ltd. insider trades: AbCellera Biologics (ABCL) stock buys and sales

10% Owner, AbCellera Biologics Last trade Feb 27, 2026 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$131K
Bought, last 12 months
1 buy
12
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thermopylae Holdings Ltd. reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 27, 2026ABCL↑ Buy$131K
Mar 11, 2025ABCL↑ Buy$742K
Aug 29, 2024ABCL↑ Buy$740K
May 26, 2023ABCL↑ Buy$998K
Dec 16, 2022ABCL↑ Buy$859K
Aug 19, 2022ABCL↑ Buy$2.3M
Jun 14, 2022ABCL↑ Buy$515K
Jun 6, 2022ABCL↑ Buy$484K
May 13, 2022ABCL↑ Buy$2.2M
May 12, 2022ABCL↑ Buy$9.0M
Nov 11, 2021ABCL↑ Buy$3.0M
Jun 9, 2021ABCL↓ Sell$134.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABCL insiders

Open-market trades in the last 12 months

About Thermopylae Holdings Ltd.'s insider trades

Thermopylae Holdings Ltd. is a 10% owner of AbCellera Biologics (ABCL). Since Jun 9, 2021, it has reported 11 open-market purchases worth $21.0M and 1 sale worth $134.5M on SEC Form 4. In the last 12 months: 1 buy ($131K).

Its filings also include gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABCL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.